Perindopril

This classification denotes an ace inhibitor with the molecular formula C19H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y5GMK36KGY, chemically known as 11h-indole-2-carboxylic acid, octahydro-1-(2-((1-ethoxycarbonyl)butyl)amino)-1-oxopropyl)-, (2s-(1(r*(r*)),2-alpha,3a-beta,7a-beta))- but generally known as perindopril, which bears US NIH Compound Identifier 60184. European Medicines Agency schedules Perindopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09730MIG. The term PERINDOPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules perindopril in its Anatomical Therapeutic Chemical (ATC) Classification. PERINDOPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule perindopril under HS 29339990 and SITC 51577. As of Q4 2014, PERINDOPRIL remains the US FDA Preferred Term for this commodity. Perindopril bears US NLM identifiers UMLS ID C0136123 and NCI Concept Code C72910. SMILES: O=C(N1C2C(CC1C(=O)O)CCCC2)C(NC(CCC)C(=O)OCC)C.